1-9 of 9
Cameron J. Turtle
Close
Sort by
Journal Articles

Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

Alexandre V. Hirayama, Erik L. Kimble, Jocelyn H. Wright, Salvatore Fiorenza, Jordan Gauthier, Jenna M. Voutsinas, Qian Wu, Cecilia C. S. Yeung, Nicolas Gazeau, Barbara S. Pender, Delaney R. Kirchmeier, Aiko Torkelson, Abigail N. Chutnik, Ryan D. Cassaday, Aude G. Chapuis, Damian J. Green, Hans-Peter Kiem, Filippo Milano, Mazyar Shadman, Brian G. Till, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2024) 8 (2): 453–467.
https://doi.org/10.1182/bloodadvances.2023011287
Published: 2024
Includes: Supplemental data
Journal Articles

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL

Clinical Trials & Observations
Emily C. Liang, Aya Albittar, Jennifer J. Huang, Alexandre V. Hirayama, Erik L. Kimble, Andrew J. Portuguese, Aude Chapuis, Mazyar Shadman, Brian G. Till, Ryan D. Cassaday, Filippo Milano, Hans-Peter Kiem, Stanley R. Riddell, Cameron J. Turtle, David G. Maloney, Jordan Gauthier
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6990–7005.
https://doi.org/10.1182/bloodadvances.2023011399
Published: 2023
Includes: Supplemental data
Journal Articles

ICANS prophylaxis: potentially transformative but elusive

Clinical Trials & Observations
Mark R. Dowling, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6782–6784.
https://doi.org/10.1182/bloodadvances.2023011027
Published: 2023
Journal Articles

A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy

Alexandre V. Hirayama, Cassie K. Chou, Takahiro Miyazaki, Rachel N. Steinmetz, Henna A. Di, Simon P. Fraessle, Jordan Gauthier, Salvatore Fiorenza, Reed M. Hawkins, Willem W. Overwijk, Stanley R. Riddell, Mario Q. Marcondes, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2479–2493.
https://doi.org/10.1182/bloodadvances.2022008697
Published: 2023
Includes: Supplemental data
Journal Articles

Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy

Clinical Trials & Observations
Krishna R. Juluri, Qian Vicky Wu, Jenna Voutsinas, Jue Hou, Alexandre V. Hirayama, Erin Mullane, Nancy Miles, David G. Maloney, Cameron J. Turtle, Merav Bar, Jordan Gauthier
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2055–2068.
https://doi.org/10.1182/bloodadvances.2020004142
Published: 2022
Includes: Supplemental data
Journal Articles

Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy

Clinical Trials & Observations
Victor A. Chow, Ajay K. Gopal, Jordan Gauthier, Yolanda D. Tseng, Cameron J. Turtle, David G. Maloney, Mazyar Shadman
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4869–4872.
https://doi.org/10.1182/bloodadvances.2020002292
Published: 2020
Journal Articles

Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia

Clinical Trials & Observations
Ryan D. Cassaday, Kelsey-Leigh A. Garcia, Jonathan R. Fromm, Mary-Elizabeth M. Percival, Cameron J. Turtle, Paul T. Nghiem, Phillip A. Stevenson, Elihu H. Estey
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3239–3245.
https://doi.org/10.1182/bloodadvances.2020002403
Published: 2020
Includes: Supplemental data
Journal Articles

Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy

Joshua A. Hill, Elizabeth M. Krantz, Kevin A. Hay, Sayan Dasgupta, Terry Stevens-Ayers, Rachel A. Bender Ignacio, Merav Bar, Joyce Maalouf, Sindhu Cherian, Xueyan Chen, Greg Pepper, Stanley R. Riddell, David G. Maloney, Michael J. Boeckh, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3590–3601.
https://doi.org/10.1182/bloodadvances.2019000717
Published: 2019
Includes: Supplemental data
Journal Articles

Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy

Mazyar Shadman, Jordan Gauthier, Kevin A. Hay, Jenna M. Voutsinas, Filippo Milano, Ang Li, Alexandre V. Hirayama, Mohamed L. Sorror, Sindhu Cherian, Xueyan Chen, Ryan D. Cassaday, Brian G. Till, Ajay K. Gopal, Brenda M. Sandmaier, David G. Maloney, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3062–3069.
https://doi.org/10.1182/bloodadvances.2019000593
Published: 2019